70978-07-3 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 3-amino-2-hydroxy-5-methylbenzoate 95+% is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the formation of complex organic molecules that can have therapeutic effects.
Used in Dye Industry:
In the dye industry, Methyl 3-amino-2-hydroxy-5-methylbenzoate 95+% is used as an intermediate in the production of dyes, where its chemical structure can be manipulated to create a variety of colorants for different applications.
Used in Organic Compounds Synthesis:
Methyl 3-amino-2-hydroxy-5-methylbenzoate 95+% is used as an intermediate in the synthesis of other organic compounds, leveraging its reactivity and structural properties to form a wide range of chemical products.
Used in Research Applications:
In research, Methyl 3-amino-2-hydroxy-5-methylbenzoate 95+% is utilized for its potential in various chemical reactions, providing insights into chemical behavior and the development of new compounds and materials.
Used in Industrial Applications:
Methyl 3-amino-2-hydroxy-5-methylbenzoate 95+% is employed in industrial processes where its chemical properties are harnessed for large-scale production of various products, including those in the pharmaceutical and dye industries.
Check Digit Verification of cas no
The CAS Registry Mumber 70978-07-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,9,7 and 8 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 70978-07:
(7*7)+(6*0)+(5*9)+(4*7)+(3*8)+(2*0)+(1*7)=153
153 % 10 = 3
So 70978-07-3 is a valid CAS Registry Number.
70978-07-3Relevant academic research and scientific papers
EQUILIBRATIVE NUCLEOSIDE TRANSPORTER ENT1 INHIBITORS
-
Page/Page column 54, (2009/06/27)
The present invention is related to novel compounds of formula (I) having equilibrative nucleoside transporter ENTl inhibiting properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment of diseases linked to the inhibition of ENTl receptors in animals, in particular humans.
Synthesis and pharmacology of 3,4-dihydro-3-oxo-1,4-benzoxazine-8-carboxamide derivatives, a new class of potent serotonin-3 (5-HT3) receptor antagonists
Kawakita,Kuroita,Yasumoto,Sano,Inaba,Fukuda,Tahara
, p. 624 - 630 (2007/10/02)
A series of 3,4-dihydro-3-oxo-1,4-benzoxazine-8-carboxamide derivatives was synthesized and evaluated for serotonin-3 (5-HT3) receptor antagonistic activity assessed by their ability to antagonize the von Bezold-Jarish (BJ) effect in rats. Derivatives bearing 1-azabicyclo[2.2.2]oct-3-yl moiety as a basic function attached to the carboxamide at position 8 showed more potent antagonistic activity than those bearing the other three basic moieties. Structure activity relationships of this series showed that methyl and chloro groups were more effective as substituents at positions 4 and 6, respectively. The representative compound 15 (Y-25130) in this series showed potent antagonistic activity on the BJ effect (ED50 = 1.3 μg/kg i.v.), high affinity for 5-HT3 receptor (K(i) = 2.9 nM) and complete protection against cisplatin-induced emesis in dogs at a dose of 0.1 mg/kg i.v.
